Tickers

1. Composite Trajectory Verdict

The income statement carries the most weight for assessing MS's financial performance given its revenue-driven, capital-light wealth and investment management businesses alongside its institutional securities franchise, where earnings trends directly reflect the firm's integrated model execution.

Composite Trajectory: Improving

The composite assessment is driven by a clear improving trend in the income statement across three comparable annual periods: net revenues rose 14% YoY in both 2024 and 2025, net income applicable to Morgan Stanley grew 50% then 27%, diluted EPS increased 54% then 28%, the expense efficiency ratio fell from 77% to 71% to 68%, ROE climbed from 9.4% to 14.0% to 16.6%, and pre-tax margin expanded from 22% to 28% to 31%. All three business segments contributed to revenue and earnings growth. The balance sheet shows mixed signals — assets, loans, deposits, and equity all grew, but capital ratios (CET1 standardized 15.9%→15.0%, SLR 5.6%→5.4%, Tier 1 leverage 6.9%→6.7%) declined modestly while borrowings outpaced deposit growth (21% vs 10%). Cash flow trajectory cannot be assessed due to missing statement of cash flows data in the provided filings.

2. Red Flags

• CET1 capital ratio (Standardized) declined from 15.9% at Dec 31, 2024 to 15.0% at Dec 31, 2025, though remaining well above the 11.8% requirement (10-K 2025-12-31, Selected Financial Information)
• Supplementary Leverage Ratio declined from 5.6% to 5.4%, and Tier 1 leverage ratio from 6.9% to 6.7% over the same period (10-K 2025-12-31, Selected Financial Information)
• Borrowings grew 21% ($288.8B→$348.9B) while deposits grew 10% ($376.0B→$415.5B), increasing reliance on wholesale funding (10-K 2025-12-31, Selected Financial Information; Borrowings by Maturity table)
• Provision for credit losses increased from $264M in 2024 to $349M in 2025, driven by portfolio growth and specific CRE loans (10-K 2025-12-31, Provision for Credit Losses)
• Severance costs of $144M recognized in 2025 from a workforce action affecting ~2% of global workforce (10-K 2025-12-31, Non-Interest Expenses)
• Non-GAAP adjusted net revenues exclude DCP mark-to-market losses of $471M in 2025 vs $363M in 2024, a widening gap (10-K 2025-12-31, Reconciliations from U.S. GAAP to Non-GAAP)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Net revenues increased 14% in both 2024 ($61.8B vs $54.1B) and 2025 ($70.6B vs $61.8B) (10-K 2025-12-31, Consolidated results). Net income applicable to Morgan Stanley grew 50% in 2024 ($12.8B vs $8.5B) and 27% in 2025 ($16.2B vs $12.8B) (10-K 2025-12-31, Consolidated results). Diluted EPS rose from $5.18 to $7.95 to $10.21 (10-K 2025-12-31, Consolidated results). Expense efficiency ratio improved from 77% to 71% to 68% (10-K 2025-12-31, Selected Financial Information). Pre-tax margin expanded from 22% to 28% to 31% (10-K 2025-12-31, Selected Financial Information). ROE increased from 9.4% to 14.0% to 16.6%; ROTCE from 12.8% to 18.8% to 21.6% (10-K 2025-12-31, Selected Financial Information). All three segments posted higher net revenues and net income in each year: Institutional Securities ($23.1B→$28.1B→$33.1B revenue; $3.5B→$6.7B→$8.7B income), Wealth Management ($26.3B→$28.4B→$31.8B revenue; $5.0B→$5.9B→$7.1B income), Investment Management ($5.4B→$5.9B→$6.5B revenue; $0.6B→$0.9B→$1.1B income) (10-K 2025-12-31, Business Segment Results).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

Overall Assessment: The statement of cash flows is not present in the provided filing excerpts. The 10-K MD&A references liquidity resources and funding management but does not present operating, investing, or financing cash flow totals for any period. The XBRL data provided covers only balance sheet and income statement concepts. Without cash flow statements for at least two comparable periods, no trajectory can be determined.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew 17% from $1,215.1B to $1,420.3B (10-K 2025-12-31, Consolidated Balance Sheets). Loans increased 17% from $246.8B to $289.0B (10-K 2025-12-31, Selected Financial Information). Deposits rose 10% from $376.0B to $415.5B (10-K 2025-12-31, Selected Financial Information). Borrowings grew 21% from $288.8B to $348.9B (10-K 2025-12-31, Selected Financial Information). Common equity increased 8% from $94.8B to $101.9B; tangible common equity rose 11% from $71.6B to $79.1B (10-K 2025-12-31, Selected Financial Information). However, regulatory capital ratios declined: CET1 (Standardized) from 15.9% to 15.0%, Tier 1 leverage from 6.9% to 6.7%, SLR from 5.6% to 5.4% (10-K 2025-12-31, Selected Financial Information). Risk-weighted assets increased under both Standardized ($471.8B→$552.5B) and Advanced ($477.3B→$514.2B) approaches (10-K 2025-12-31, RWA Rollforward). The firm remains well above all regulatory minimums.

6. Data Gaps

• Statement of cash flows for any period (operating, investing, financing cash flows) — would require the full 10-K cash flow statement or 10-Q cash flow statements
• Quarterly income statement, balance sheet, and cash flow data for Q1-Q3 2025 and Q1-Q2 2026 — the 10-Q filings are listed but their content is not provided in the document set
• Segment-level non-interest expense breakdowns for all periods — only aggregate compensation/non-compensation provided in MD&A
• Detailed credit loss provisions by segment for 2023 — only 2024 and 2025 disclosed in MD&A text
• Off-balance sheet commitments and contingencies quantitative data — referenced but not quantified in provided excerpts